A significant proportion of patients with heart failure who have poor creatinine clearance have been deprived of the benefits of mineralocorticoid receptor blockade, owing to genuine concerns of life-threatening hyperkalemia. This evidence concerns the gene NR3C2 and Hyperkalemia.